Free energy methods for pharmaceutical drug discovery
We had a great last year with four graduate students joining the lab and four graduating! Welcome Hannah, Martin, Chris and Tran! Congratulations to Guilherme, Camilla, Caitlin and Nathan!
I’m behind on updates,but there’s a lot of great news recently! Here are some highlights.
Lab news and events:
First year graduate students Danielle Bergazin, Jessica Maat and Noora Siddiqui recently joined the lab. This is in addition to a rotation by Daniel Seith.
We also have great news on the funding front — huge congratulations to Noora, who was just awarded a prestigious DOE CSGF to support her graduate studies! [More…]
The Open Forcefield Consortium [http://openforcefield.org] seeks a Lead Software Scientist to coordinate open source software development efforts for an interdisciplinary academic team developing next-generation molecular mechanics forcefields and associated parameterization infrastructure.
This exciting new initiative spans several academic institutions and will be supported by a pharmaceutical industry consortium, with potential for long-term support from the NIH and other agencies. [More…]
A modern journal paradigm for molecular simulation:
Open access, nonprofit, low cost, and updateable
The Living Journal of Computational Molecular Science (LiveCoMS) is a peer-reviewed, ultra-low-cost, open-access journal that invites your submissions. LiveCoMS seeks to bring publication of educational, review, and best practices materials into the modern age, allowing authors to publish their work but then continue its development. LiveCoMS also attempts to better align academic incentives with the realities of computational work that require development of community resources. [More…]
We’re super excited that the 2018 Workshop on Free Energy Methods is coming together for May, 2018, at Novartis in Cambridge, MA! I’ve really enjoyed this workshop over the years — it’s been a great opportunity to see the field, grow, mature, and shift from a meeting where there are a lot of spectators from the pharmaceutical industry who hope these calculations might eventually be of use, to one where we get to hear about the latest applications, challenges, and successes in industrial applications. [More…]